Sr. Director, External Alternative CMC, Boehringer Ingelheim
Sammy Bell, Ph.D.
Adjunct Professor
Education
- Ph.D., Chemistry / Pharmacology, University of Rhode Island, 2017
- M.S., Chemistry, University of Rhode Island, 2007
- B.S., Chemistry, University of Connecticut, 2002
Other Professional Experience
- Boehringer Ingelheim Animal Health (Merial), Duluth, Georgia (Aug 2016 – Present)
- Alcon Laboratories (Novartis), Johns Creek, Georgia (Nov 2012 – Aug 2016)
- Pfizer Global Research and Development, Groton Connecticut (2002 – 2012)
Areas of Expertise
- Process chemistry experience from R&D through late stage manufacturing
- Pharmaceutical Scientist with expertise from pre-formulation to late stage formulation development (Ph I/II/III) of parenteral and solid oral dosage forms
- Discovery Chemistry / Research Formulations / Oral Controlled Release / Product Enhancement
- Drug Delivery and Drug Product Development / Manufacture
